Teva Pharmaceuticals USA triple therapy, LANSOPRAZOLE DR Capsules USP 30mg, CLARITHROMYCIN recall — FDA D-1499-2014
Failed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obtained during stability testing for Lansoprazole.